TY - JOUR
T1 - Polycystic ovary syndrome
AU - Norman, Robert J.
AU - Dewailly, Didier
AU - Legro, Richard S.
AU - Hickey, Theresa E.
N1 - Funding Information:
RSL has served as a consultant to Glaxo Smith Kline and Ferring, and has received lecture fees from Serono, meeting support from Abbott, and grant support from Pfizer. Other authors declare that they have no conflict of interest.
PY - 2007/8/25
Y1 - 2007/8/25
N2 - Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.
AB - Polycystic ovary syndrome is a heterogeneous endocrine disorder that affects about one in 15 women worldwide. The major endocrine disruption is excessive androgen secretion or activity, and a large proportion of women also have abnormal insulin activity. Many body systems are affected in polycystic ovary syndrome, resulting in several health complications, including menstrual dysfunction, infertility, hirsutism, acne, obesity, and metabolic syndrome. Women with this disorder have an established increased risk of developing type 2 diabetes and a still debated increased risk of cardiovascular disease. The diagnostic traits of polycystic ovary syndrome are hyperandrogenism, chronic anovulation, and polycystic ovaries, after exclusion of other conditions that cause these same features. A conclusive definition of the disorder and the importance of the three diagnostic criteria relative to each other remain controversial. The cause of polycystic ovary syndrome is unknown, but studies suggest a strong genetic component that is affected by gestational environment, lifestyle factors, or both.
UR - http://www.scopus.com/inward/record.url?scp=34548039205&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548039205&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(07)61345-2
DO - 10.1016/S0140-6736(07)61345-2
M3 - Review article
C2 - 17720020
AN - SCOPUS:34548039205
SN - 0140-6736
VL - 370
SP - 685
EP - 697
JO - Lancet
JF - Lancet
IS - 9588
ER -